Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Field Trip Health Ltd (FTRPF)

Field Trip Health Ltd (FTRPF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Field Trip Health Ltd. to Commence Trading on the NASDAQ on July 29, 2021 Under the Symbol FTRP

TORONTO, July 27, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP; FTRP.WT; OTCQX: FTRPF) ("Field Trip" or the “Company”), a global leader in the development and delivery of psychedelic...

FTRP.TO : 1.09 (+5.83%)
FTRPF : 5.7460 (-2.32%)
FTRP-WT.TO : 0.0050 (unch)
Field Trip Health Ltd. Obtains Conditional Approval to List on Nasdaq Under the Symbol "FTRP"

TORONTO, July 23, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP; FTRP.WT; OTCQX: FTRPF) ("Field Trip" or the “Company”), a global leader in the development and delivery of psychedelic...

FTRP.TO : 1.09 (+5.83%)
FTRPF : 5.7460 (-2.32%)
Field Trip Health Ltd. to Present at the Cowen Psychedelics & Novel Mechanisms in Neuropsychiatry Summit

TORONTO, July 08, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP; FTRP.WT; OTCQX: FTRPF) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, announced...

FTRP.CN : 5.550 (+1.46%)
FTRPF : 5.7460 (-2.32%)
Life Sciences Companies Investor Presentations Now Available for On-Demand Viewing

Individual and institutional investors as well as advisors are invited to log-on to LifeSciencesInvestorForum.com to view presentations

CLXPF : 3.0200 (-1.31%)
BABYF : 0.0198 (-1.00%)
SHIEF : 0.0366 (-40.39%)
INNPF : 0.1464 (+38.77%)
LEXX : 2.16 (-1.82%)
DFFN : 6.60 (+11.68%)
FTRPF : 5.7460 (-2.32%)
INM : 4.65 (+9.93%)
ARHH : 7.6500 (-4.38%)
VNRX : 0.8110 (+0.12%)
AVCRF : 0.0462 (+8.71%)
SPHRY : 0.7500 (+0.12%)
Field Trip Health Ltd. Reports Fiscal Fourth Quarter and Full Year 2021 Financial Results

TORONTO, June 24, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP; FTRP.WT; OTCQX: FTRPF) ("Field Trip"), a leader in the development and delivery of psychedelic therapies, reported its fiscal...

FTRP.CN : 5.550 (+1.46%)
FTRPF : 5.7460 (-2.32%)
Virtual Conference for Life Sciences Companies Broadcast Live June 24th, 2021

Company executives will share corporate vision and answer audience questions at LifeSciencesInvestorForum.com

VNRX : 0.8110 (+0.12%)
LEXX : 2.16 (-1.82%)
DFFN : 6.60 (+11.68%)
INM : 4.65 (+9.93%)
CLXPF : 3.0200 (-1.31%)
BABYF : 0.0198 (-1.00%)
SHIEF : 0.0366 (-40.39%)
INNPF : 0.1464 (+38.77%)
FTRPF : 5.7460 (-2.32%)
ARHH : 7.6500 (-4.38%)
AVCRF : 0.0462 (+8.71%)
SPHRY : 0.7500 (+0.12%)
Field Trip Health Ltd. Schedules Fiscal Fourth Quarter and Full Year 2021 Financial Results Conference Call for Friday, June 25, 2021 At 8:00 am ET

TORONTO, June 17, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP; FTRP.WT; OTCQX: FTRPF) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, announced...

FTRP.CN : 5.550 (+1.46%)
FTRPF : 5.7460 (-2.32%)
“The Science Behind Using Psychedelics To Treat Mental Health Disorders And Addiction Is Compelling”

Jim Cramer discussed psychedelics on his June 15, 2021 program and said big drug companies tried, and failed, to treat major depression. Here are four psychedelic companies you need to know about that...

MNMD : 7.09 (-5.72%)
EHVVF : 0.0001 (-90.00%)
CMPS : 4.45 (-4.51%)
LKYSF : 0.4800 (-3.63%)
FTRPF : 5.7460 (-2.32%)
Recent Surge for Intellectual Property & Patents in Psychedelic Therapies & Drug Development

Palm Beach, FL – June 15, 2021 – The modern psychedelic renaissance has empirically proven that psychedelic drugs are going to revolutionize mental health treatment. Before these incredibly promising...

OILFF : 0.0562 (+12.40%)
OILS.CN : 0.0700 (unch)
MNMD : 7.09 (-5.72%)
LKYSF : 0.4800 (-3.63%)
NUMI.VN : 0.580 (+9.43%)
FTRPF : 5.7460 (-2.32%)
FTRP.CN : 5.550 (+1.46%)
CRTPF : 2.3000 (+5.50%)
CRDL.TO : 2.22 (+1.83%)
Field Trip Health Ltd. Announces Completion of DMPK Studies, Engineering Batch for FT-104, Its Novel Psychedelic Compound

Completion of These Critical Steps Positions Company to Submit Application to Commence Phase 1 Human Trials by Year End

FTRP.CN : 5.550 (+1.46%)
FTRPF : 5.7460 (-2.32%)

Barchart Exclusives

2 Energy Dividend Stocks Yielding 6% to Pick Now
These two have been favorites among income-focused investors due to their high and consistent distribution yield. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar